Protagenic Therapeutics Inc (NASDAQ:PTIX) currently has a daily average trading volume of 2.08M but it saw 13438588 shares traded in last market. With a market cap of 1.71M USD, the company’s current market price of $0.23 came falling about -9.20 while comparing to the previous closing price of $0.25. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.87 and as low as $0.18. In the recent trading on the day, stock has struck highest price mark of $0.225 while lowest mark touched by it was $0.2552.
Taking a look at 20-day trading activity of Protagenic Therapeutics Inc (PTIX) gives us an average price of $0.2656, while its current price level is -87.86% below from 52-week high level whereas it is 26.82% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.3017 while that of 200 days or SMA-200 reads an average of $0.5670. A closer look into the stock’s movement over the week reveals that its volatility is standing at 18.73% during that period while stretching the period over a month that decreases to 15.35%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.27 which implies that the stock is in neutral territory.
Over the week, PTIX’s stock price is moving -13.69% down while it is -38.33% when we observe its performance for the past one month. Year-to-date it is -53.67% down and over the past year, the stock is showing a downside performance of -87.53%.
The company is expected to be releasing its next quarterly report in May, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Protagenic Therapeutics Inc’s total number of outstanding shares is 7.24M with 13.43% of that held by the insiders while 5.38% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -545.36% and return on equity (ROE) at -236.06%. Stock has a price to book (P/B) ratio of 1.62. Its return on asset (ROA) is -175.99% on average.
